clinical trials

Talaris lays off 95% of workforce, C-suite as kidney transplant company fails to find a savior
Talaris lays off 95% of workforce, C-suite as kidney transplant company fails to find a savior
Fierce Biotech
Talaris Therapeutics
clinical trials
kidney transplants
Flag link:
Prothena leverages Walgreens’ capabilities to accelerate development of Alzheimer’s Drug
Prothena leverages Walgreens’ capabilities to accelerate development of Alzheimer’s Drug
Medical Marketing and Media
Prothena
PRX012
fast track
Walgreens
clinical trials
Flag link:
Zenshine’s Phase ll influenza therapy trial meets primary endpoint
Zenshine’s Phase ll influenza therapy trial meets primary endpoint
Clinical Trials Arena
Zenshine
clinical trials
ZX-7107A
influenza
Flu
Flag link:
MindMed Collaborators Announce Positive Phase II Results for LSD in Major Depressive Disorder
MindMed Collaborators Announce Positive Phase II Results for LSD in Major Depressive Disorder
Genetic Engineering News
MindMed
clinical trials
lysergide
LSD
major depressive disorder
Flag link:
Schizophrenia: Four major clinical trials to watch in 2023
Schizophrenia: Four major clinical trials to watch in 2023
Clinical Trials Arena
clinical trials
schizophrenia
Reviva
brilaroxazine
Newron
evenamide
Sunovion
ulotaront
Acadia Pharma
pimavanserin
Flag link:
Bridge doses first patient in Phase lla trial of IPF therapy
Bridge doses first patient in Phase lla trial of IPF therapy
Clinical Trials Arena
Bridge Biotherapeutics
clinical trials
BBT-877
IPF
Flag link:
Pragmatica: Lung cancer trial tests streamlined design, inclusive eligibility
Pragmatica: Lung cancer trial tests streamlined design, inclusive eligibility
RAPS.org
Project Pragmatica
National Cancer Institute
non-small cell lung cancer
clinical trials
Flag link:
FDA outlines risk-based approach to monitoring clinical trials
FDA outlines risk-based approach to monitoring clinical trials
RAPS.org
clinical trials
regulatory
FDA
risk
Flag link:
Horizon's (HZNP) Tepezza Meets Goals in TED Expanded Use Study
Horizon's (HZNP) Tepezza Meets Goals in TED Expanded Use Study
Zacks.com
Horizon Therapeutics
Tepezza
clinical trials
thyroid eye disease
Flag link:
Shionogi starts global Phase II clinical trial of redasemtide
Shionogi starts global Phase II clinical trial of redasemtide
Clinical Trials Arena
Shionogi
clinical trials
redasemtide
stroke
Flag link:
FDA places partial hold on Molecular Templates’ Phase I trial
FDA places partial hold on Molecular Templates’ Phase I trial
Clinical Trials Arena
Molecular Templates
MT-0169
Multiple Myeloma
clinical trials
Flag link:
Breaking the mold: How digital endpoints could transform clinical trials
Breaking the mold: How digital endpoints could transform clinical trials
Clinical Trials Arena
clinical trials
digital endpoints
endpoints
Flag link:
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
BioSpace
Merck
Keytruda
Eisai
Lenvima
melanoma
clinical trials
cancer
colorectal cancer
Flag link:
Q1 claimed the highest number of trial starts in 2022
Q1 claimed the highest number of trial starts in 2022
Clinical Trials Arena
clinical trials
Flag link:
In NEJM, full Pfizer data show RSV vaccine’s protection
In NEJM, full Pfizer data show RSV vaccine’s protection
BioPharma Dive
Pfizer
RSV
vaccines
clinical trials
NEJM
Flag link:
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Flag link:
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
Endpoints
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
clinical trials
Flag link:
BenevolentAI lead atopic dermatitis drug misses the mark
BenevolentAI lead atopic dermatitis drug misses the mark
Pharmaphorum
BenevolentAI
clinical trials
BEN-2293
atopic dermatitis
Flag link:
Promising candidate for NASH submitted to FDA as IND
Promising candidate for NASH submitted to FDA as IND
Clinical Trials Arena
NeuroBo
FDA
clinical trials
NASH
Flag link:
Kodiak Sciences begins subject treatment in DME therapy trial
Kodiak Sciences begins subject treatment in DME therapy trial
Clinical Trials Arena
Kodiak Sciences
clinical trials
diabetic macular edema
KSI-501
Flag link:

Pages